Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 1

Interventions

Specimen Handling 454 Magnetic Resonance Spectroscopy 347 pembrolizumab 289 Biopsy 244 Carboplatin 230 Cisplatin 194 Cyclophosphamide 186 Paclitaxel 164 Nivolumab 154 Gemcitabine 151 Radiotherapy 125 Bevacizumab 124 Dexamethasone 113 fludarabine 100 Pemetrexed 99 Fluorouracil 94 Doxorubicin 92 durvalumab 91 Radiation 91 Docetaxel 91 venetoclax 89 Rituximab 88 Oxaliplatin 88 atezolizumab 87 Leucovorin 79 Capecitabine 76 Prednisone 75 Lenalidomide 70 Etoposide 69 X-Rays 66

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

tisotumab vedotin × 30 days × Clear all

NCT06459180 2026-05-27

TroFuse-020

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡